Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 104,252
▲ 490% vs 2024
Profit
Caution€ -631,558
▼ 38% vs 2024
Debts
High€ 934,909
▼ 20% vs 2024
272BIO from Gent, company number BE0762638249, closed financial year 2025 with a result of € -631,558 after tax. For that financial year 272BIO recorded a gross margin of € 104,252 and equity of € -225,308. Compared with financial year 2024, the result moved from € -457,209 to € -631,558. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 12, 2026.
What happened at 272BIO?
What happened at 272BIO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 631,558. Source: NBB ↗
- Tom Hayward became a director. NBB
- Christine Labeur became a director. NBB
- Liz Littlewood became a director. NBB
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Charles Edward Owen became a director. NBB
In short
From € 70,217 loss in 2022 to € 631,558 loss in 2025.
Paid € 2,657 in corporate taxes since 2022.
On average € 20,000 of value added per employee in 2025.
A new publication or filing at 272BIO? We notify you, reason included.
Follow 272BIONeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind 272BIO are Charles Edward Owen, Tom Hayward, Christine Labeur and Liz Littlewood. The same people are also behind Xpert Protein.
Directors
According to the 2025 annual accounts
since 2021
since 2024
since 2024
since 2024
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
ORIONIS BIOSCIENCES
€ 11.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
S-Biomedic
€ 4.4 million gross margin · 2025
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
+11 more
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
GOOGLE - Google LLC, US
Domain
Domain
272bio.com
Registered
2019-10-19
Registrar
Mesh Digital Limited
Expires
2027-10-19
Website info
Features
Security
Details
- Company number
- 0762.638.249
- VAT number
- BE 0762.638.249
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- 272BIO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 January 2021
- Peppol
- Active · Active since 13 Apr 2026
- Contact
- 272bio.com info@272bio.com
- Activities · NACE
Vervaardiging van geneesmiddelen